Профиль IR Biosciences Holdings Inc
IR Biosciences Holdings, Inc. operates as a development stage biotechnology company. The company focuses on the research and development of therapies in the areas of pulmonary fibrosis, influenza infection and radiation-induced Neutropenia. Its other areas of research include vaccine adjuvant activity evinced against certain forms of cancer and applications for wound healing and for regenerating or strengthening the human immune system, in part, through stimulating human adult stem cells. The company was founded on June 4, 1985 and is headquartered in Scottsdale, AZ.